{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:03:36Z","timestamp":1790067816462,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,9,7]],"date-time":"2011-09-07T00:00:00Z","timestamp":1315353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00345-011-0757-1","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T11:47:31Z","timestamp":1315309651000},"page":"59-67","source":"Crossref","is-referenced-by-count":60,"title":["Epidemiology, treatment and prevention of healthcare-associated urinary tract infections"],"prefix":"10.1007","volume":"30","author":[{"given":"F. M. E.","family":"Wagenlehner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mete","family":"Cek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt G.","family":"Naber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kiyota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truls E.","family":"Bjerklund-Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,7]]},"reference":[{"key":"757_CR1","volume-title":"Nosocomial and Health Care Associated Infections in Urology","author":"TM Hooton","year":"2001","unstructured":"Hooton TM, Carlet JM, Duse AG, Krieger JN, Steele L, Sunakawa K (2001) Definitions and epidemiology. In: Naber KG, Pechere JC, Kumazawa J, Khoury S, Gerberding JL, Schaeffer AJ (eds) Nosocomial and Health Care Associated Infections in Urology. Health Publication, Plymouth"},{"issue":"5","key":"757_CR2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA (2008) CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5):309\u2013332","journal-title":"Am J Infect Control"},{"issue":"1","key":"757_CR3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0195-6701(98)90173-6","volume":"38","author":"P Gastmeier","year":"1998","unstructured":"Gastmeier P, Kampf G, Wischnewski N, Hauer T, Schulgen G, Schumacher M et al (1998) Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect 38(1):37\u201349","journal-title":"J Hosp Infect"},{"issue":"4","key":"757_CR4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01713142","volume":"25","author":"H Ruden","year":"1997","unstructured":"Ruden H, Gastmeier P, Daschner FD, Schumacher M (1997) Nosocomial and community-acquired infections in Germany. Summary of the results of the First National Prevalence Study (NIDEP). Infection 25(4):199\u2013202","journal-title":"Infection"},{"issue":"2","key":"757_CR5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3201\/eid0702.010240","volume":"7","author":"DG Maki","year":"2001","unstructured":"Maki DG, Tambyah PA (2001) Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 7(2):342\u2013347","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"757_CR6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/501964","volume":"23","author":"PA Tambyah","year":"2002","unstructured":"Tambyah PA, Knasinski V, Maki DG (2002) The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol 23(1):27\u201331","journal-title":"Infect Control Hosp Epidemiol"},{"key":"757_CR7","first-page":"575","volume-title":"Urogenital infections","author":"FME Wagenlehner","year":"2010","unstructured":"Wagenlehner FME, Cek M, Kiyota H, Bjerklund-Johansen TE (2010) Epidemiology, treatment and prevention of health-care associated urinary tract infections. In: Naber KG, Schaeffer AJ, Heyns C, Matsumoto T, Shoskes D, Bjerklund-Johansen TE (eds) Urogenital infections. European Association of Urology\u2014International Consultation on Urological Diseases, Arnhem, pp 575\u2013588"},{"key":"757_CR8","unstructured":"US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research (1992) pp 115\u2013127"},{"issue":"3","key":"757_CR9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1166-7087(07)92383-0","volume":"17","author":"P Abrams","year":"2007","unstructured":"Abrams P, Khoury S, Grant A (2007) Evidence\u2013based medicine overview of the main steps for developing and grading guideline recommendations. Prog Urol 17(3):681\u2013684","journal-title":"Prog Urol"},{"issue":"12 Suppl","key":"757_CR10","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/nm1145","volume":"10","author":"SB Levy","year":"2004","unstructured":"Levy SB, Marshall B (2004) Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 10(12 Suppl):S122\u2013S129","journal-title":"Nat Med"},{"issue":"11","key":"757_CR11","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-136-11-200206040-00013","volume":"136","author":"N Safdar","year":"2002","unstructured":"Safdar N, Maki DG (2002) The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 136(11):834\u2013844","journal-title":"Ann Intern Med"},{"issue":"3","key":"757_CR12","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3201\/eid0403.980320","volume":"4","author":"RA Weinstein","year":"1998","unstructured":"Weinstein RA (1998) Nosocomial infection update. Emerg Infect Dis 4(3):416\u2013420","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"757_CR13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","volume":"32","author":"National Nosocomial Infections Surveillance (NNIS)","year":"2004","unstructured":"National Nosocomial Infections Surveillance (NNIS) (2004) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32(8):470\u2013485","journal-title":"Am J Infect Control"},{"key":"757_CR14","unstructured":"Cited 2011 02.06.2011. Available from: http:\/\/www.cdc.gov\/nhsn\/PDFs\/dataStat\/2010NHSNReport.pdf"},{"issue":"10","key":"757_CR15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1198-743x.2001.00324.x","volume":"7","author":"E Bouza","year":"2001","unstructured":"Bouza E, San Juan R, Munoz P, Voss A, Kluytmans J (2001) A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study group on nosocomial infection. Clin Microbiol Infect 7(10):532\u2013542","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"757_CR16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.eururo.2006.08.012","volume":"51","author":"TE Bjerklund Johansen","year":"2007","unstructured":"Bjerklund Johansen TE, Cek M, Naber K, Stratchounski L, Svendsen MV, Tenke P (2007) Prevalence of hospital-acquired urinary tract infections in urology departments. Eur Urol 51(4):1100\u20131112","journal-title":"Eur Urol"},{"key":"757_CR17","doi-asserted-by":"crossref","unstructured":"Tandogdu Z, Cek M, Tenke P, Naber K, Bjerklund Johansen TE (2010) Prevalence of nosocomial urinary tract infections: what has changed in years. In: European Urology Supplements. 25th Anniversary EAU congress 2010. European Association of Urology, Barcelona, p 171","DOI":"10.1016\/S1569-9056(10)60478-2"},{"issue":"4","key":"757_CR18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.eururo.2006.03.056","volume":"50","author":"KG Naber","year":"2006","unstructured":"Naber KG (2006) Urogenital infections: the pivotal role of the urologist. Eur Urol 50(4):657\u2013659","journal-title":"Eur Urol"},{"issue":"Suppl 1","key":"757_CR19","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.ijantimicag.2006.05.005","volume":"28","author":"TE Johansen","year":"2006","unstructured":"Johansen TE, Cek M, Naber KG, Stratchounski L, Svendsen MV, Tenke P (2006) Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies. Int J Antimicrob Agents 28(Suppl 1):S91\u2013S107","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"757_CR20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ajic.2006.09.006","volume":"35","author":"N Graves","year":"2007","unstructured":"Graves N, Tong E, Morton AP, Halton K, Curtis M, Lairson D et al (2007) Factors associated with health care-acquired urinary tract infection. Am J Infect Control 35(6):387\u2013392","journal-title":"Am J Infect Control"},{"issue":"7","key":"757_CR21","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00134-003-1767-2","volume":"29","author":"M Leone","year":"2003","unstructured":"Leone M, Albanese J, Garnier F, Sapin C, Barrau K, Bimar MC et al (2003) Risk factors of nosocomial catheter-associated urinary tract infection in a polyvalent intensive care unit. Intensive Care Med 29(7):1077\u20131080","journal-title":"Intensive Care Med"},{"issue":"7","key":"757_CR22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajic.2006.03.001","volume":"34","author":"S Saint","year":"2006","unstructured":"Saint S, Kaufman SR, Rogers MA, Baker PD, Boyko EJ, Lipsky BA (2006) Risk factors for nosocomial urinary tract-related bacteremia: a case-control study. Am J Infect Control 34(7):401\u2013407","journal-title":"Am J Infect Control"},{"issue":"3","key":"757_CR23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00430-010-0161-2","volume":"199","author":"U Dobrindt","year":"2010","unstructured":"Dobrindt U, Chowdary MG, Krumbholz G, Hacker J (2010) Genome dynamics and its impact on evolution of Escherichia coli. Med Microbiol Immunol 199(3):145\u2013154","journal-title":"Med Microbiol Immunol"},{"key":"757_CR24","first-page":"5","volume":"50","author":"A Tambi\u0107","year":"1996","unstructured":"Tambi\u0107 A, Tambi\u0107 T, Ku\u010di\u0161ec-Tepe\u0161 N (1996) Prevalence and antibiotic sensitivity pattern variations of bacterial isolates in different settings and different periods of time. Acta med Croatica 50:5\u201310","journal-title":"Acta med Croatica"},{"issue":"1","key":"757_CR25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0732-8893(98)00158-8","volume":"35","author":"RN Jones","year":"1999","unstructured":"Jones RN, Kugler KC, Pfaller MA, Winokur PL (1999) Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn Microbiol Infect Dis 35(1):55\u201363","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"757_CR26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0732-8893(01)00254-1","volume":"40","author":"D Mathai","year":"2001","unstructured":"Mathai D, Jones RN, Pfaller MA (2001) Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis 40(3):129\u2013136","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"757_CR27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1198-743x.2001.00326.x","volume":"7","author":"E Bouza","year":"2001","unstructured":"Bouza E, San Juan R, Munoz P, Voss A, Kluytmans J (2001) A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin Microbiol Infect 7(10):523\u2013531","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"757_CR28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0924-8579(02)00093-6","volume":"19","author":"FM Wagenlehner","year":"2002","unstructured":"Wagenlehner FM, Krcmery S, Held C, Klare I, Witte W, Bauernfeind A et al (2002) Epidemiological analysis of the spread of pathogens from a urological ward using genotypic, phenotypic and clinical parameters. Int J Antimicrob Agents 19(6):583\u2013591","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"757_CR29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1086\/427507","volume":"40","author":"LE Nicolle","year":"2005","unstructured":"Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM (2005) Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 40(5):643\u2013654","journal-title":"Clin Infect Dis"},{"issue":"1","key":"757_CR30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00345-005-0042-2","volume":"24","author":"LE Nicolle","year":"2006","unstructured":"Nicolle LE, Zhanel GG, Harding GK (2006) Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria. World J Urol 24(1):61\u201365","journal-title":"World J Urol"},{"issue":"1","key":"757_CR31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/AAC.45.1.13-22.2001","volume":"45","author":"GL Drusano","year":"2001","unstructured":"Drusano GL, Preston SL, Hardalo C, Hare R, Banfield C, Andes D et al (2001) Use of preclinical data for selection of a phase II\/III dose for evernimicin and identification of a preclinical MIC breakpoint. Antimicrob Agents Chemother 45(1):13\u201322","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"757_CR32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/dkg028","volume":"51","author":"G Kahlmeter","year":"2003","unstructured":"Kahlmeter G (2003) An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS project. J Antimicrob Chemother 51(1):69\u201376","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"757_CR33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0732-8893(02)00467-4","volume":"45","author":"KA Gordon","year":"2003","unstructured":"Gordon KA, Jones RN (2003) Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe, Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn Microbiol Infect Dis 45(4):295\u2013301","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3\u20134","key":"757_CR34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0924-8579(99)00019-9","volume":"11","author":"T Goto","year":"1999","unstructured":"Goto T, Nakame Y, Nishida M, Ohi Y (1999) Bacterial biofilms and catheters in experimental urinary tract infection. Int J Antimicrob Agents 11(3\u20134):227\u2013231 (discussion 37\u201339)","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"757_CR35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1179\/joc.2003.15.6.563","volume":"5","author":"F Pea","year":"2003","unstructured":"Pea F, Pavan F, Di Qual E, Brollo L, Nascimben E, Baldassarre M et al (2003) Urinary pharmacokinetics and theoretical pharmacodynamics of intravenous levofloxacin in intensive care unit patients treated with 500\u00a0mg b.i.d. for ventilator-associated pneumonia. J Chemother 5(6):563\u2013567","journal-title":"J Chemother"},{"issue":"3","key":"757_CR36","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/jac\/dkn229","volume":"62","author":"X Zhao","year":"2008","unstructured":"Zhao X, Drlica K (2008) A unified anti-mutant dosing strategy. J Antimicrob Chemother 62(3):434\u2013436","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"757_CR37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0163-4453(97)93194-7","volume":"35","author":"G Elhanan","year":"1997","unstructured":"Elhanan G, Sarhat M, Raz R (1997) Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection. J Infect 35(3):283\u2013288","journal-title":"J Infect"},{"issue":"1","key":"757_CR38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00120-002-0265-4","volume":"42","author":"E Wagenlehner","year":"2003","unstructured":"Wagenlehner E, Niemetz A, Naber G (2003) Spectrum of pathogens and resistance to antibiotics in urinary tract infections and the consequences for antibiotic treatment: study of urology inpatients with urinary tract infections (1994\u20132001). Urologe A 42(1):13\u201325","journal-title":"Urologe A"},{"key":"757_CR39","first-page":"1","volume-title":"European Association of Urology Guidelines","author":"M Grabe","year":"2009","unstructured":"Grabe M, Bishop M, Bjerklund-Johansen TE, Botto H, Cek M, Lobel B, Naber KG, Palou J, Tenke P, Wagenlehner F (2009) Guidelines on urological infections. In: EAo Urology (ed) European Association of Urology Guidelines. European Association of Urology, Arnhem, pp 1\u2013110"},{"issue":"Suppl 1","key":"757_CR40","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.ijantimicag.2007.07.033","volume":"31","author":"P Tenke","year":"2008","unstructured":"Tenke P, Kovacs B, Bjerklund Johansen TE, Matsumoto T, Tambyah PA, Naber KG (2008) European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents 31(Suppl 1):S68\u2013S78","journal-title":"Int J Antimicrob Agents"},{"issue":"21","key":"757_CR41","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1001\/archinte.160.21.3294","volume":"160","author":"TB Karchmer","year":"2000","unstructured":"Karchmer TB, Giannetta ET, Muto CA, Strain BA, Farr BM (2000) A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med 160(21):3294\u20133298","journal-title":"Arch Intern Med"},{"issue":"3","key":"757_CR42","first-page":"152","volume":"88","author":"I Al-Habdan","year":"2003","unstructured":"Al-Habdan I, Sadat-Ali M, Corea JR, Al-Othman A, Kamal BA, Shriyan DS (2003) Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. Int Surg 88(3):152\u2013154","journal-title":"Int Surg"},{"issue":"4","key":"757_CR43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/SLA.0b013e31819a0315","volume":"249","author":"U Pfefferkorn","year":"2009","unstructured":"Pfefferkorn U, Lea S, Moldenhauer J, Peterli R, von Flue M, Ackermann C (2009) Antibiotic prophylaxis at urinary catheter removal prevents urinary tract infections: a prospective randomized trial. Ann Surg 249(4):573\u2013575","journal-title":"Ann Surg"},{"issue":"5","key":"757_CR44","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/archinte.160.5.678","volume":"160","author":"PA Tambyah","year":"2000","unstructured":"Tambyah PA, Maki DG (2000) Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med 160(5):678\u2013682","journal-title":"Arch Intern Med"},{"key":"757_CR45","doi-asserted-by":"crossref","unstructured":"Bach T, Netsch C, Haecker A, Michel MS, Herrmann TR, Gross AJ (2010) Thulium: YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 28(1):39\u201343","DOI":"10.1007\/s00345-009-0461-6"},{"key":"757_CR46","doi-asserted-by":"crossref","unstructured":"Lourenco T, Shaw M, Fraser C, MacLennan G, N\u2019Dow J, Pickard R (2010) The clinical effectiveness of transurethral incision of the prostate: a systematic review of randomised controlled trials. World J Urol 28(1):23\u201332","DOI":"10.1007\/s00345-009-0496-8"},{"issue":"6","key":"757_CR47","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/j.1939-4640.1991.tb00288.x","volume":"12","author":"JE Oesterling","year":"1991","unstructured":"Oesterling JE (1991) A permanent, epithelializing stent for the treatment of benign prostatic hyperplasia. Preliminary results. J Androl 12(6):423\u2013428","journal-title":"J Androl"},{"issue":"9","key":"757_CR48","first-page":"933","volume":"47","author":"HW Gottfried","year":"1994","unstructured":"Gottfried HW, Schlmers HP, Gschwend J, Brandle E, Hautmann RE (1994) Thermosensitive stent (Memotherm) for the treatment of benign prostatic hyperplasia. Arch Esp Urol 47(9):933\u2013943","journal-title":"Arch Esp Urol"},{"key":"757_CR49","first-page":"14","volume":"206","author":"M Ala-Opas","year":"1993","unstructured":"Ala-Opas M, Talja M, Tiitinen J, Hellstrom P, Heikkinen A, Nurmi M (1993) Prostakath in urinary outflow obstruction. Ann Chir Gynaecol Suppl 206:14\u201318","journal-title":"Ann Chir Gynaecol Suppl"},{"issue":"3","key":"757_CR50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1464-410X.1993.tb00728.x","volume":"72","author":"AL Poulsen","year":"1993","unstructured":"Poulsen AL, Schou J, Ovesen H, Nordling J (1993) Memokath: a second generation of intraprostatic spirals. Br J Urol 72(3):331\u2013334","journal-title":"Br J Urol"},{"key":"757_CR51","doi-asserted-by":"crossref","unstructured":"Moore KN, Fader M, Getliffe K (2007) Long-term bladder management by intermittent catheterisation in adults and children. Cochrane Database Syst Rev (4):CD006008","DOI":"10.1002\/14651858.CD006008.pub2"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-011-0757-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-011-0757-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-011-0757-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T20:21:19Z","timestamp":1712780479000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-011-0757-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["757"],"URL":"https:\/\/doi.org\/10.1007\/s00345-011-0757-1","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,7]]}}}